Sarah H. Plummer

4.3k total citations
4 papers, 256 citations indexed

About

Sarah H. Plummer is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Sarah H. Plummer has authored 4 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in Sarah H. Plummer's work include Influenza Virus Research Studies (3 papers), Hepatitis B Virus Studies (1 paper) and Respiratory viral infections research (1 paper). Sarah H. Plummer is often cited by papers focused on Influenza Virus Research Studies (3 papers), Hepatitis B Virus Studies (1 paper) and Respiratory viral infections research (1 paper). Sarah H. Plummer collaborates with scholars based in United States. Sarah H. Plummer's co-authors include Galina V. Yamshchikov, Barney S. Graham, Mary E. Enama, Richard A. Koup, Robert T. Bailer, John R. Mascola, Julie E. Ledgerwood, Gary J. Nabel, Richard Schwartz and Zonghui Hu and has published in prestigious journals such as The Lancet, Clinical and Vaccine Immunology and Contemporary Clinical Trials.

In The Last Decade

Sarah H. Plummer

4 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah H. Plummer United States	4	173	154	86	52	41	4	256
Stacey T. M. Cheung Australia	11	125 0.7×	62 0.4×	68 0.8×	57 1.1×	53 1.3×	11	234
Jane Ennis United States	13	184 1.1×	97 0.6×	68 0.8×	61 1.2×	48 1.2×	18	286
Nolwenn Nougarede France	8	145 0.8×	130 0.8×	73 0.8×	38 0.7×	46 1.1×	13	270
Solomiia Khomandiak United States	4	199 1.2×	172 1.1×	46 0.5×	34 0.7×	30 0.7×	5	262
Viswanathan Ramasamy India	8	200 1.2×	214 1.4×	54 0.6×	44 0.8×	44 1.1×	9	304
Robert S. Adcock United States	8	119 0.7×	108 0.7×	79 0.9×	33 0.6×	72 1.8×	10	253
Chia Yin Lee Singapore	7	165 1.0×	170 1.1×	35 0.4×	34 0.7×	28 0.7×	8	243
Vicky Roy United States	9	165 1.0×	130 0.8×	68 0.8×	64 1.2×	68 1.7×	14	317
Ter Yong Tan Singapore	7	174 1.0×	220 1.4×	76 0.9×	32 0.6×	70 1.7×	10	307
Dawne K. Rowe United States	4	162 0.9×	145 0.9×	58 0.7×	17 0.3×	44 1.1×	5	243

Countries citing papers authored by Sarah H. Plummer

Since Specialization

Citations

This map shows the geographic impact of Sarah H. Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. Plummer more than expected).

Fields of papers citing papers by Sarah H. Plummer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah H. Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. Plummer. The network helps show where Sarah H. Plummer may publish in the future.

Co-authorship network of co-authors of Sarah H. Plummer

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. Plummer. A scholar is included among the top collaborators of Sarah H. Plummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. Plummer. Sarah H. Plummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

DeZure, Adam, Emily E. Coates, Zonghui Hu, et al.. (2017). An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. npj Vaccines. 2(1). 15–15. 20 indexed citations

2.

Ledgerwood, Julie E., Zonghui Hu, Pamela Costner, et al.. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary Clinical Trials. 44. 112–118. 11 indexed citations

3.

Chang, Lee-Jah, Kimberly A. Dowd, Floreliz Mendoza, et al.. (2014). Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet. 384(9959). 2046–2052. 182 indexed citations

4.

Ledgerwood, Julie E., Ingelise J. Gordon, Galina V. Yamshchikov, et al.. (2012). Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans. Clinical and Vaccine Immunology. 19(11). 1792–1797. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact